Skip to main content
. 2020 Nov 19;5(6):e001021. doi: 10.1136/esmoopen-2020-001021

Table 2.

Symptom description by stage and number of symptoms present at diagnosis of non-small cell lung cancer*

Symptoms at diagnosis Not present Stage at diagnosis
I II III IV P for trend
Cough 5723 (67.0) 158 (1.8) 208 (2.4) 919 (10.7) 1533 (17.9) <0.001
Pain 6203 (72.6) 88 (1.0) 131 (1.5) 535 (6.3) 1584 (18.5) <0.001
Dyspnoea 6352 (74.4) 121 (1.4) 133 (1.5) 620 (7.2) 1315 (15.4) <0.001
Haemoptysis 7561 (88.5) 58 (0.6) 99 (1.1) 399 (4.7) 424 (5.0) <0.001
Weight loss 6778 (79.4) 41 (0,5) 83 (1.0) 466 (5.4) 1173 (13.7) <0.001
Anorexia 8059 (94.4) 11 (0.1) 27 (0.3) 121 (1.4) 323 (3.4) <0.001
Asthenia 7767 (90.9) 28 (0.3) 48 (0.6) 194 (2.3) 504 (5.9) <0.001
Superior vena cava syndrome 8517 (99.7) 0 0 11 (0.1) 13 (0.2) 0.419
Aphonia or voice alterations 8304 (97.2) 5 (0.0) 14 (0.2) 77 (0.9) 141 (1.6) 0.004
Number of symptoms
0
1
2
3
4 or more
n/a n/a n/a n/a n/a 489 (59.3)
202 (24.5)
102 (12.4)
23 (2.8)
5 (1.0)
307 (42.5)
201 (27.8)
131 (18.1)
63 (8.7)
21 (2.9)
724 (30.2)
669 (27.9)
538 (22.5)
304 (12.7)
159 (6.6)
1276 (27.7)
1300 (28.3)
983 (21.4)
625 (13.6)
416 (9.0)
<0.001
0.127
<0.001
<0.001
<0.001

*Tumours with unknown status excluded.